20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2079 | GSK126 | GSK2816126A,EZH2 inhibitor | Histone Methyltransferase |
GSK126 (GSK2816126A) is a excellently specific EZH2 methyltransferase inhibitor ( IC50=9.9 nM). | |||
T6484 | EI1 | KB-145943,Ezh2 inhibitor | Apoptosis , Histone Methyltransferase |
EI1 (Ezh2 inhibitor) is a potent and selective EZH2 inhibitor with IC50 of 15 nM and 13 nM for EZH2 (WT) and EZH2 (Y641F), respectively. | |||
T7305 | JQEZ5 | Histone Methyltransferase | |
JQEZ5 is an inhibitor of EZH2 lysine methyltransferase (IC50 = 11.1 nM). | |||
T25400 | EZH2-IN-3 | EZH2 inhibitor 3,EZH2-inhibitor-3 | |
EZH2-IN-3 is an inhibitor of EZH2 and EZH1 with selective impact on diffuse large B cell lymphoma cell growth. | |||
T12428L | PF-06726304 | Histone Methyltransferase | |
PF-06726304 shows robust antitumor growth activity. PF-06726304 is an effective and selective EZH2 inhibitor. PF-06726304 inhibits wild-type and Y641N mutant EZH2 (Kis: 0.7 and 3.0 nM, respectively). | |||
T1788 | Tazemetostat | E-7438,EPZ6438 | Histone Methyltransferase |
Tazemetostat (EPZ6438) is a histone methyltransferase EZH2 inhibitor (IC50=11 nM) that is orally active, selective, and SAM-competitive. Tazemetostat exhibits antitumor activity and may be used for the treatment of epith... | |||
T17002 | Tazemetostat hydrobromide | E-7438 hydrobromide,EPZ-6438 hydrobromide | Histone Methyltransferase |
Tazemetostat hydrobromide (E-7438 hydrobromide) is a potent and selective EZH2 inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 (Ki: 2.5 n... | |||
T9700 | EZH2-IN-2 | Histone Methyltransferase | |
EZH2-IN-2 is a EZH2 inhibitor with an IC50 of 64 nM. | |||
T64043 | EZH2-IN-13 | Histone Methyltransferase | |
EZH2-IN-13 is a potent EZH2 inhibitor with potential anticancer activity.EZH2-IN-13 may be used to study diseases associated with EZH2 activity. | |||
T2435 | EPZ011989 | Histone Methyltransferase | |
EPZ011989 is a effective, specific orally bioavailable EZH2 inhibitor with Ki < 3 nM for EZH2 Y646 and EZH2 wt; 15-fold selectivity over EZH1 and >3000-fold selectivity over other HMTase. | |||
T6809 | CPI-169 racemate | CPI 169,CPI-169,CPI169 | Epigenetic Reader Domain , Histone Methyltransferase |
CPI-169 racemate (CPI 169) is a potent, and selective EZH2 inhibitor with IC50 of 0.24 nM, 0.51 nM, and 6.1 nM for EZH2 WT, EZH2 Y641N, and EZH1, respectively. | |||
T1775 | GSK503 | Histone Methyltransferase | |
GSK-503, a potent EZH2 inhibitor, has potential antitumor activity. | |||
T12430 | PF-06821497 | Histone Methyltransferase | |
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition. | |||
T1905 | EPZ005687 | Histone Methyltransferase | |
EPZ005687 is a potent and selective inhibitor of EZH2. | |||
T67883 | EZH2-IN-15 | SHR2554 | Histone Methyltransferase |
EZH2-IN-15 is a specific inhibitor of histone modifier enhancer of zeste 2 (EZH2). EZH2 is aberrantly overexpressed in a number of human cancers that controls the adaptive response via regulation of Treg activity. Intrat... | |||
T6810 | CPI-360 | Synonym 2,CPI 360,CPI360 | Apoptosis , Histone Methyltransferase |
CPI-360 is a small molecule EZH2 inhibitor (IC50: 0.002 μM, EC50: 0.080 μM) that shows antitumor activity in an EZH200-dependent tumor xenograft model. | |||
T3057 | UNC1999 | Histone Methyltransferase , Autophagy | |
UNC1999 is a orally bioavailable, effective and specific inhibitor of EZH2 (IC50=2 nM) and EZH1 (IC50=45). | |||
T15194 | EBI-2511 | Histone Methyltransferase | |
EBI-2511 is a highly potent and orally active inhibitor of EZH2 (IC50: 6 nM in Pfeffiera cell lines). | |||
T8201 | Gambogenic acid | Histone Methyltransferase | |
Gambogenic acid is a natural product,is an effective inhibitor of EZH2,with anticancer activity. | |||
T6059 | GSK343 | Histone Methyltransferase , Autophagy | |
GSK343, a specific and effective EZH2 inhibitor (IC50=4 nM), exhibits 60 fold specificity activity against EZH1, and >1000 fold specificity activity against other histone methyltransferases. |